These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 36584935)

  • 1. CD8
    Wang Q; Qin Y; Li B
    Cancer Lett; 2023 Apr; 559():216043. PubMed ID: 36584935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8
    Huang Y; Jia A; Wang Y; Liu G
    Immunology; 2023 Jan; 168(1):30-48. PubMed ID: 36190809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
    Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H
    Front Immunol; 2020; 11():622509. PubMed ID: 33633741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8
    Zhang B; Liu J; Mo Y; Zhang K; Huang B; Shang D
    Front Immunol; 2024; 15():1476904. PubMed ID: 39372416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor microenvironment shapes the molecular characteristics of exhausted CD8
    Cheng H; Ma K; Zhang L; Li G
    Cancer Lett; 2021 May; 506():55-66. PubMed ID: 33662493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 T-cell heterogeneity during T-cell exhaustion and PD-1-targeted immunotherapy.
    Ando S; Araki K
    Int Immunol; 2022 Oct; 34(11):571-577. PubMed ID: 35901837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy.
    He QF; Xu Y; Li J; Huang ZM; Li XH; Wang X
    Brief Funct Genomics; 2019 Mar; 18(2):99-106. PubMed ID: 29554204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinvigorating exhausted CD8
    Hossain MA; Liu G; Dai B; Si Y; Yang Q; Wazir J; Birnbaumer L; Yang Y
    Med Res Rev; 2021 Jan; 41(1):156-201. PubMed ID: 32844499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer.
    Zhang L; Zhang B; Li L; Ye Y; Wu Y; Yuan Q; Xu W; Wen X; Guo X; Nian S
    J Cancer Res Clin Oncol; 2023 May; 149(5):2243-2258. PubMed ID: 36107246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TOX promotes the exhaustion of antitumor CD8
    Wang X; He Q; Shen H; Xia A; Tian W; Yu W; Sun B
    J Hepatol; 2019 Oct; 71(4):731-741. PubMed ID: 31173813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion.
    Li F; Wang Y; Chen D; Du Y
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of Cbl-b inhibits CD8
    Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation.
    Fu Y; Wang J; Liu C; Liao K; Gao X; Tang R; Fan B; Hong Y; Xiao N; Xiao C; Liu WH
    Cell Mol Immunol; 2023 Oct; 20(10):1127-1139. PubMed ID: 37553428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.
    Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel T cell exhaustion gene signature to predict prognosis and immunotherapy response in thyroid carcinoma from integrated RNA-sequencing analysis.
    Li Y; Wang Z; Lu F; Miao Y; Feng Q; Zhu W; Kang Q; Chen Y; Zhang Q
    Sci Rep; 2024 Apr; 14(1):8375. PubMed ID: 38600248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer.
    Zhang J; Lei F; Tan H
    Front Immunol; 2023; 14():1166128. PubMed ID: 37275913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to reinvigorate exhausted CD8
    Guan Q; Han M; Guo Q; Yan F; Wang M; Ning Q; Xi D
    Front Immunol; 2023; 14():1204363. PubMed ID: 37398660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.
    Bae EA; Seo H; Kim BS; Choi J; Jeon I; Shin KS; Koh CH; Song B; Kim IK; Min BS; Han YD; Shin SJ; Kang CY
    Cancer Res; 2018 Sep; 78(18):5315-5326. PubMed ID: 30012672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4
    Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8
    Kurachi M
    Semin Immunopathol; 2019 May; 41(3):327-337. PubMed ID: 30989321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.